- Home
- QURE vs HBT Comparison
QURE vs HBT Comparison
Compare QURE & HBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QURE | HBT |
|---|---|---|
| Founded | 1998 | 1920 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | QURE | HBT |
|---|---|---|
| Price | $40.30 | $32.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $45.00 | $30.75 |
| AVG Volume (30 Days) | ★ 2.9M | 222.9K |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 3.29% |
| EPS Growth | ★ 29.67 | 7.96 |
| EPS | N/A | ★ 0.34 |
| Revenue | ★ $13,107,000.00 | N/A |
| Revenue This Year | $126.12 | $35.73 |
| Revenue Next Year | $200.43 | $7.01 |
| P/E Ratio | ★ N/A | $98.13 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $22.36 |
| 52 Week High | $71.50 | $33.70 |
Technical Indicators
Market Signals| Indicator | QURE | HBT |
|---|---|---|
| Relative Strength Index (RSI) | 51.94 | 63.13 |
| Support Level | $39.50 | $31.20 |
| Resistance Level | $50.47 | $33.10 |
| Average True Range (ATR) | 2.49 | 0.88 |
| MACD | -1.21 | -0.02 |
| Stochastic Oscillator | 17.71 | 64.51 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About HBT HBT Financial Inc.
HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking. It generates revenue from Card income, Wealth management fees, and Service charges on deposit accounts.